Sumatriptan Succinate Injection
Product Images NDC 85766-238

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 85766-238). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig (Fig)

A line graph comparing the estimated percentage of subjects experiencing relief over time (0 to 25 minutes) for Sumatriptan versus Placebo. The graph shows higher relief percentages for Sumatriptan, with data points plotted for 0, 5, 10, 15, 20, and 25 minutes, indicating increased efficacy over time compared to Placebo.*

FDA Label Image

Fig1 (Fig1)

Sumatriptan Succinate Injection USP 6 mg/0.5 mL in a prefilled, subcutaneous injection device manufactured by Sportpharm LLC. The image shows the pen-like injector with a clear cartridge and a white and blue housing, labeled with product name, strength, dose, route, and labeler details.*

FDA Label Image

Fig10 (Fig10)

An instructional illustration showing a hand holding a Sumatriptan Succinate subcutaneous injection device pressed against skin. A clock icon indicates a 5-second pause, with text instructing to wait before lifting the injector from the skin.*

FDA Label Image

Fig11 (Fig11)

An instructional image showing a person's hand holding a Sumatriptan Succinate injection pen at the point of subcutaneous administration. The diagram includes a label indicating to "Take the pen off your skin," highlighting the step after injection delivery.*

FDA Label Image

Fig12 (Fig12)

An illustration of a red biohazard sharps container with a white lid and a circular opening on the top. The front prominently displays a warning label featuring a biohazard symbol and the word "WARNING BIOHAZARD." This container is typically used for the safe disposal of used needles and other medical sharps.*

FDA Label Image

Fig2 (Fig2)

An instructional diagram of a Sumatriptan Succinate 6 mg/0.5 mL subcutaneous injection pen by Sportpharm LLC. The pen is shown horizontally with labeled parts: a cap that must be removed before use, a medicine window to check the liquid clarity, and a blue button to press firmly for injection initiation.*

FDA Label Image

Fig3 (Fig3)

Illustration showing proper injection sites for Sumatriptan Succinate 6 mg/0.5 mL subcutaneous injection. The image depicts administration into the thigh and arm, demonstrating how to hold the syringe against the skin.*

FDA Label Image

Fig4 (Fig4)

An instructional diagram illustrating the appearance of a Sumatriptan Succinate subcutaneous injection before and after administration. The first image shows the injection with clear liquid inside, while the second shows the blue plunger rod filling the window after the injection is completed.*

FDA Label Image

Fig5 (Fig5)

An illustration showing how to pull the cap straight off a Sumatriptan Succinate 6 mg/0.5 mL subcutaneous injection pen. The image features a hand holding the pen and another hand beginning to remove the cap, with arrows indicating the direction to pull the cap off.*

FDA Label Image

Fig6 (Fig6)

Two photographic illustrations showing the correct and incorrect positioning of a component on a beige plastic device, possibly a part of an injection pen or syringe mechanism. The top image marked with a green check shows the component properly aligned and inserted, while the bottom image marked with a red X shows the component misaligned or improperly positioned. The images are labeled as Figure E.*

FDA Label Image

Fig7 (Fig7)

Instructional diagram showing the correct technique for subcutaneous injection using Sumatriptan Succinate injection. A hand is pressing the injector at a 90-degree angle against the skin with an arrow indicating downward pressure and a label stating 'Press down against skin to unlock.' The diagram is labeled as Figure F.*

FDA Label Image

Fig8 (Fig8)

An instructional illustration showing a hand holding a Sumatriptan Succinate injection device at a 90-degree angle to the skin, demonstrating the pressing action for subcutaneous injection. The image includes labels indicating where to press and that a clicking sound confirms activation.*

FDA Label Image

Fig9 (Fig9)

An instructional illustration showing subcutaneous injection of Sumatriptan Succinate with a hand pressing the injection device against skin. A callout highlights that the blue plunger moves down and completely fills the medicine window after injection.*

FDA Label Image

1 (Label)

Packaging labels for Sumatriptan Succinate Injection USP Autoinjector System 6 mg/0.5 mL by Sportpharm LLC. Two labels shown: one for NDC 85766-238-01 with quantity 1 and another for NDC 85766-238-02 with quantity 2. Labels include distribution by Dr. Reddy's Laboratories Inc., prescription drug status, dosage form as subcutaneous injection, and storage instructions.*

FDA Label Image

Stru (Stru)

Chemical structure diagram of Sumatriptan Succinate showing its molecular components and bonds, including the sulfonamide and succinate groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.